“Viral Pathogens” Featuring Dr. James Crowe

On this episode of the Immunology Podcast, Dr. James Crowe talks about his team's work on the first known case of COVID-19 in the USA, the versatility of monoclonal antibodies for disease prevention and treatment, and preparing for the next pandemic.

Dr. James Crowe is the Director of the Vanderbilt Vaccine Center, which uses molecular and cellular biology, state-of-the-art imaging and flow cytometry, bioinformatics, and bioengineering approaches to study major human pathogens. He talks about his monoclonal antibody discovery program for COVID-19 and other viruses.

It was fascinating to learn about Dr. Crowe’s quest to generate monoclonal antibody therapeutics for every viral infection, which can be invaluable tools against emerging diseases.

Dr. Brenda Raud, host

Find more episodes at immunologypodcast.com or wherever you get your podcasts.

This Episode's Immunology Roundup:

Publish Date: November 02, 2022